Vibeke Stevenius Ringsdal

Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

E. Hjardem, Mikkel Østergaard, Jan Pødenphant et al. · Annals of the Rheumatic Diseases · 2007 · 99 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry

Merete Lund Hetland, Hanne Lindegaard, Axel Kornerup Hansen et al. · Annals of the Rheumatic Diseases · 2008 · 77 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry

Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Pernille Bøyesen et al. · Annals of the Rheumatic Diseases · 2012 · 30 citations

Medicine, Pharmacotherapy, Radiology +15

Improving long-term survival of patients with acute myocardial infarction from 1977-1988 in a region of Denmark

C. Torp-Pedersen, Per Hildebrandt, Finn Erland Nielsen et al. · European Heart Journal · 1995 · 17 citations

Medicine, Cardiology, Clinical Cardiology +15

Reduced infarct size in nonreperfused myocardial infarction by combined infusion of isosorbide dinitrate and streptokinase

Per Hildebrandt, Christian Torp-Pedersen, T. Joen et al. · American Heart Journal · 1992 · 16 citations

Medicine, Cardiology, Pharmacology +17